Research Briefing | Oct 8, 2021

India | Vaccine surge to energize consumption in 2022

report image for Vaccine surge to energize consumption in 2022

We still think India’s recovery will be subdued in H2 2021, despite a significant pick-up in vaccinations from August. The uptick in inoculations is mostly first doses, and it will take time for second doses to be administered. As per our estimates, around 40% of the population will be fully vaccinated by end 2021.

What you will learn from this report:

  • Based on the latest data, we have brought forward our timeline for 70% of the population to be fully vaccinated to Q1 2022, from Q2 earlier.
  • This should provide a strong fillip to sentiment early next year and spur consumption.
  • In the short-term, the relatively low proportion of the fully vaccinated will likely keep consumers cautious and constrain the recovery in services and manufacturing.
  • Mounting supply-side disruption are also a drag on momentum.
Tags: APACASEANAsiaAsia PacificAsian EconomyCoronavirusCoronavirus vaccineCovid crisisCovid restrictionsCovid19Global economicsGlobal economyIndiaMarketsSEASouth East AsiaVaccine programmesVaccine rolloutVaccines
Back to Resource Hub

Related Services

Takaichi’s big win doesn’t affect the fiscal outlook for Japan

Takaichi’s big win doesn’t affect the fiscal outlook for Japan

The ruling Liberal Democratic Party's (LDP) landslide election victory on Sunday doesn't change our expectation of a primary fiscal deficit of 2%-3% of GDP in FY2026-FY2028 – we still see the deficit only starting to decline from FY2029. We also keep our view that the 10-year Japanese government bond (JGB) yield will be at 2.3% at end-2026 and 2.5% at end-2027 and beyond.
US and Chinese strength won’t boost all other economies

US and Chinese strength won’t boost all other economies

Upward revisions to US and Chinese GDP growth in Q4 meant that the previously anticipated soft end to 2025 failed to materialise.